Why Atossa Therapeutics Soared 20% Higher Today
Atossa Therapeutics (NASDAQ: ATOS) stock closed just over 20% higher on Tuesday. The surge was due to a modest but impactful price target raise from an analyst tracking the company.
Prognosticator Edward Woo lifted said price target on Atossa to an even $8 per share from the previous $7.75. The new level is slightly more than twice the most recent closing price of the clinical-stage biotech. Almost needless to say, Woo has a buy rating on the stock; this remained unchanged with the price target raise.
Image source: Getty Images.
Source Fool.com
